ISIS 416858
ISIS 416858 CS4
Phase 2 small_molecule completed
Quick answer
ISIS 416858 for End-stage Renal Disease (ESRD) is a Phase 2 program (small_molecule) at IONIS PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- IONIS PHARMACEUTICALS INC
- Indication
- End-stage Renal Disease (ESRD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed